Sanofi ADR(SNY) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 22.07 | EPS (ttm) | 1.94 | Insider Own | - | Shs Outstand | 2.43B | Perf Week | -3.43% |
| Market Cap | 102.13B | Forward P/E | 8.11 | EPS next Y | 6.49% | Insider Trans | - | Shs Float | 2.38B | Perf Month | -1.45% |
| Enterprise Value | 122.24B | PEG | 1.14 | EPS next Q | 1.63 | Inst Own | 7.99% | Short Float | 0.31% | Perf Quarter | -4.2% |
| Income | 4.69B | P/S | 1.91 | EPS this Y | 6.18% | Inst Trans | -0.17% | Short Ratio | 2.21 | Perf Half Y | -2.55% |
| Sales | 53.47B | P/B | 1.31 | EPS next 5Y | 7.13% | ROA | 3.12% | Short Interest | 7.32M | Perf YTD | -11.58% |
| Book/sh | 32.59 | P/C | 14.07 | EPS past 3/5Y | -11.86% -15.52% | ROE | 5.7% | 52W High | -18.66% ($52.68) | Perf Year | -9.69% |
| Cash/sh | 3.05 | P/FCF | 8.47 | Sales past 3/5Y | 2.9% 3.69% | ROIC | 4.8% | 52W Low | 4.79% ($40.89) | Perf 3Y | -20.04% |
| Dividend Est. | $2.45 (5.72%) | EV/EBITDA | 5.44 | EPS Y/Y TTM | -30.9% | Gross Margin | 66.29% | Volatility(W/M) | 1.67% 1.27% | Perf 5Y | -12.19% |
| Dividend TTM | 2.42 | EV/Sales | 2.29 | Sales Y/Y TTM | 23.68% | Oper. Margin | 27.17% | ATR (14) | 0.76 | Perf 10Y | 9.92% |
| Dividend Ex-Date | 2026/5/4 | Quick Ratio | 0.64 | EPS Q/Q | -32.22% | Profit Margin | 8.78% | RSI (14) | 36.7 | Recom | 2.12 |
| Dividend Gr. 3/5Y | 8.45% 5.14% | Current Ratio | 0.99 | Sales Q/Q | 18.71% | SMA20 | -3.92% ($44.6) | Beta | 0.3 | Target Price | $50 |
| Payout | 73.36% | Debt/Eq | 0.34 | Earnings | 2026/7/30 | SMA50 | -2.41% ($43.91) | Rel Volume | 0.59 | Prev Close | $43.15 |
| Employees | 76493 | LT Debt/Eq | 0.24 | EPS/Sales Surpr. | 3.11% 3.35% | SMA200 | -6.17% ($45.67) | Avg Volume(3M) | 3.31M | Price | $42.85 |
| IPO | 2002/7/1 | Option/Short | Yes/Yes | Trades | 14215 | Volume | 1,945,434 | Change | -0.71% |
Company
SNY is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
💊 This is a U.S. ADR of Sanofi, a global large-cap pharmaceutical company headquartered in France. It supplies treatments for immune and inflammatory diseases, vaccines, and consumer healthcare products to global markets, and maintains a stable revenue stream centered on its specialty care portfolio, including Dupixent, as well as influenza and respiratory vaccines.
Over the past 1 year, on the lower side
19% below its 1-year high.
SNY earns at a steady pace
27.17% of revenue is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by +6.2% this year.
Tap to view numbers
The stock looks undervalued
Trading at 22.1 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 2 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -20.0% if bought 5 years ago.
Tap to view numbers
Dividends are paid consistently
Pays 5.72% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 8.0%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
EWQ 0.04%
XEML 0.04%
PPH 0.04%
IDNA 0.04%
HEDJ 0.03%It ranks #4 in the industry
Based on market cap of $102B.
SNY $102B PER 22.1
LLY $1.1T PER 38.2
JNJ $644B PER 31.0
ABBV $443B PER 70.9
실적분석 · 7/30 Sanofi ($SNY) 2026 Q2 Earnings Analysis — Guidance Raised on Dupixent and New Product Surge; Pipeline Cleanup Drags on After-Hours Trading 투자 가이드 · 4/11 2026 U.S. High-Dividend Stock Guide — How to Screen Out the Traps 투자 가이드 · 4/1 US Stock Taxes Complete Guide 2026 — Calculation Methods and Tax-Saving Strategies for Beginners See all posts on this stock FAQ
What kind of company is SNY?
SNY belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.
What is the market cap of SNY?
The market cap of SNY is approximately $102.1B, ranking 164 within its sector.
Does SNY pay dividends?
SNY has a dividend yield of approximately 5.72%, with an annual dividend of $2.45.
What is the P/E ratio of SNY?
SNY has a P/E ratio of approximately 22.1x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for SNY?
SNY has recorded a 52-week high of $52.68 and a low of $40.89.
